Clinical Trial Update: Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

MOR103 was studied in a Phase 1/2 trial for active rheumatoid arthritis, reporting safety data and preliminary efficacy results. The results were posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MOR103

Snippet

Sponsor: MorphoSys AG | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-08